To evaluate the immunohistochemical expression of VEGF-C. CD34 and VEGFR-2 in cancer tissue of children diagnosed with stadium 4 neuroblastoma (NB) and correlate their presence with the survival rate of children diagnosed with that stage of the disease. Eighteen children assigned to stadium 4 composed the study group. Fourteen patients (allocated to stadium 3) formed a control group. https://www.roneverhart.com/Arjo-Sara-Stedy-Stand-Assist-Manual-Patient-Standing-Aid/